Article

An American Journal of Managed Care Medical Crossfire: Management of Newer Ultra-Long Acting Basal Insulin Agents in Diabetes

https://www.pharmacytimes.org/landing/1139

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Michael Hassett, MD, MPH, Dana-Farber Cancer Institute
Emilie Aschenbrenner, PharmD, BCOP, Froedtert Health and the Medical College of Wisconsin
Clayton Irvine, PharmD, MBA, MS
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo